Scientific instruments manufacturer Formulaction has been acquired by Microtrac MRB, a Verder Group company
Microtrac MRB, the particle characterization segment of Verder Group, has acquired Formulaction, which will be integrated into the group’s scientific division.
Founded in 1994 by Gérard Meunier, Formulaction is a manufacturer of cutting-edge instrumentation used in research and development for the characterization of physical stability, particle size, phase transitions and rheological properties of liquid dispersions. Formulaction is the inventor of Turbiscan, the world reference in stability analysis. The company employs 36 people and is headquartered in Toulouse, France, supported by two subsidiaries in Columbus, Ohio, in the USA and Aichach, Germany.
Microtrac MRB is a subsidiary of Verder Group. A leading manufacturer of particle characterization instruments and technologies, Microtrac MRB’s products are used for measuring and analyzing particle size, shape, surface area and other properties in various industries, including pharmaceuticals, chemicals, minerals and materials research.
Verder Group is a global industrial company that specializes in manufacturing and distributing high-quality equipment and solutions for various industries, including laboratory, process and fluid handling. The group offers a wide range of products, such as pumps, mixers, samplers and analytical instruments.
After 25 years of development, Formulaction’s founder Gérard Meunier started to transfer responsibilities to key managers three years ago, anticipating the transaction for the group. After a competitive process involving strategic acquirors from all over the world, Verder Group was chosen as the best strategic fit to work alongside the company’s management. Verder Group has acquired 100% of shares.
Oaklins’ team in France served as the exclusive financial advisor to Formulaction’s shareholders throughout the sale process. The team approached several acquirors worldwide and negotiated the most attractive deal for the sellers.
Gérard Meunier
Founder, Formulaction
Talk to the deal team
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Learn more